Related Experiment Video
Updated: Jul 7, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
Published on: August 16, 2024
[Effect of treatment with amiodarone on sinus node function]
Abstract:
Treatment with amiodarone is often associated with sinus bradycardia. We studied 477 patients (mean age 48.7 +/- 0.7 years) with various cardiac rhythm disturbances. Most patients had ischemic heart disease. Average saturation dose of amiodarone was 809.4 +/- 13.4 mg/day, average maintenance dose - 263.2 +/- 5.4 mg/day, average duration of follow-up - 20.85 +/- 1.2 months. Regular Holter ECG monitoring was used for detection of sinus bradycardia (heart rate less than 60/min). Sinus bradycardia was registered in 32 and 11.2% of patients during saturation with amiodarone and maintenance treatment, respectively. Bradycardia usually improved after lowering of amiodarone dose. Heart rate slowing was not pronounced and required neither cessation of amiodarone administration nor electrical cardiac pacing.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

